Variant report

Variant	nsv947599
Chromosome Location	chr10:26076303-26081220
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 185 )
Associated
traits (count: 40 )

Variant overlapped rSNPs/rCNVs (count:185 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs189156858	chr10:26076323-26076324	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs112362701	chr10:26076343-26076344	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs76172573	chr10:26076386-26076387	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs147951175	chr10:26076409-26076410	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs536831709	chr10:26076423-26076424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs570827223	chr10:26076427-26076428	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs373927042	chr10:26076441-26076442	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs539833285	chr10:26076445-26076446	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs549745248	chr10:26076446-26076447	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs570063468	chr10:26076448-26076449	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs535739238	chr10:26076449-26076450	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs141774622	chr10:26076555-26076556	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs566267720	chr10:26076556-26076557	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs147080146	chr10:26076562-26076563	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs202125550	chr10:26076602-26076603	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs114085784	chr10:26076757-26076758	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs543471204	chr10:26076767-26076768	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs556993286	chr10:26076774-26076775	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs574024422	chr10:26076776-26076777	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs542949973	chr10:26076791-26076792	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs192017451	chr10:26076830-26076831	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs150323281	chr10:26076834-26076835	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs369802187	chr10:26076835-26076836	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs373530980	chr10:26076847-26076848	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs184213438	chr10:26076893-26076894	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs139456020	chr10:26076939-26076940	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs370140679	chr10:26076942-26076943	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs2505495	chr10:26077232-26077233	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs137949089	chr10:26077256-26077257	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs533250986	chr10:26077297-26077298	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs558755695	chr10:26077317-26077318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs12244082	chr10:26077330-26077331	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs2442834	chr10:26077335-26077336	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs189016110	chr10:26077337-26077338	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs549289530	chr10:26077397-26077398	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs191522265	chr10:26077424-26077425	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs546417747	chr10:26077472-26077473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs34516354	chr10:26077485-26077486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs558046750	chr10:26077495-26077496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs566570253	chr10:26077522-26077523	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs554922302	chr10:26077564-26077565	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs529051147	chr10:26077567-26077568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs10508705	chr10:26077588-26077589	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs573680761	chr10:26077591-26077592	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs377600013	chr10:26077618-26077619	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs372211516	chr10:26077622-26077623	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs2437411	chr10:26077703-26077704	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs144909645	chr10:26077818-26077819	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs573035063	chr10:26077829-26077830	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs545238004	chr10:26077855-26077856	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:40)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Autism	21439084	CNVD
Maculopathy	20981449	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21525872	CNVD
Adrenocortical carcinoma	18281524	CNVD

Chromatin state (count:20 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:26066200-26076400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
2	chr10:26066200-26082800	Weak transcription	HUES6 Cell Line	embryonic stem cell
3	chr10:26069000-26077600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr10:26069800-26082800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr10:26072200-26077000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr10:26073200-26076800	Weak transcription	HUES48 Cell Line	embryonic stem cell
7	chr10:26073400-26076400	Enhancers	Brain Germinal Matrix	brain
8	chr10:26076200-26077200	Enhancers	ES-I3 Cell Line	embryonic stem cell
9	chr10:26076400-26077000	Enhancers	iPS-20b Cell Line	embryonic stem cell
10	chr10:26076800-26078400	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr10:26077000-26078200	Enhancers	iPS-18 Cell Line	embryonic stem cell
12	chr10:26077000-26078400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
13	chr10:26077200-26079000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
14	chr10:26077600-26078200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr10:26078200-26078600	Enhancers	H9 Cell Line	embryonic stem cell
16	chr10:26078400-26078600	Enhancers	iPS-15b Cell Line	embryonic stem cell
17	chr10:26078400-26078600	Enhancers	iPS-20b Cell Line	embryonic stem cell
18	chr10:26079000-26079200	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr10:26081000-26081600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr10:26081000-26081800	Enhancers	Pancreatic Islets	Pancreatic Islet

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links